OSTARINE

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

85332057

Registration number

4104772

Mark type

Stylized text

Filed

27 May 2011

Published for opposition

13 Dec 2011

Registered

28 Feb 2012

Attorney of record

Jacqueline Zion

Goods and services

• Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the prevention or treatment of any disease related to muscle wasting or androgen testosterone deficiency, including but not limited to cancer, kidney disease, HIV infection, hypogonadism, cardiovascular disease, pulmonary disease, atherosclerosis, osteoporosis, bone disorders, dry eye, meibomian gland disease, appetite disorders, frailty, metabolic syndrome, obesity, wasting disorders, depression or sexual dysfunction

Owner

• ONCTERNAL THERAPEUTICS, INC., SAN DIEGO, CA, US
• GTx, Inc., Memphis, TN, US
• GTx, Inc., Memphis, TN, US
• GTx, Inc., Memphis, TN, US

Prosecution history

• 09 Sept 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
• 28 Feb 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 17 Jul 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 16 Jul 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 16 Jul 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 22 Mar 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 22 Mar 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 22 Mar 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 09 Mar 2018 — TEAS SECTION 8 & 15 RECEIVED
• 28 Feb 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 28 Feb 2012 — REGISTERED-PRINCIPAL REGISTER
• 13 Dec 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 13 Dec 2011 — PUBLISHED FOR OPPOSITION
• 23 Nov 2011 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 09 Nov 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED